Position in UTHR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$980,195
+$666,407 QoQ
Shares Held
1,653
+156.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 76.5275257108288.ToString("F0")%
Shared 0.ToString("F0")%
None 23.472474289171206.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Lido Advisors, LLC holds $13,162,070 across 14 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
56,855 | $4,312,451 | |
| 2 | ZTS |
Zoetis Inc.
|
17,207 | $2,034,038 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
371,629 | $2,006,796 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,653 | $980,195 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,197 | $608,333 | |
| 6 | HLN |
Haleon plc
|
59,908 | $599,679 | |
| 7 | HROW |
Harrow, Inc.
|
16,470 | $580,732 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
22,886 | $423,848 |
All Filings in UTHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $980,195 | 1,653 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $313,788 | 644 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $241,045 | 575 | Shares | Sole | 2025-11-14 | |
| 2021-09-30 | $286,837 | 1,554 | Shares | Sole | 2022-02-15 | |
| 2020-06-30 | $256,036 | 2,116 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $205,686 | 2,169 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||